https://sciencehub.novonordisk.com/scientific-publications/articles/original-article.11131100.insulin-aspart-vs-human-insulin-in-the.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.11812750.bedtime-administration-of-nn2211-a-long-acting.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.11935150.the-pharmacokinetics-pharmacodynamics-safety.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.14617230.comparison-of-thrice-daily-high-vs-medium.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.15992160.insulin-aspart-a-novel-rapid-acting-human.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.26458540.drug-related-risk-of-severe-hypoglycaemia-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.26489970.incretin-therapies-highlighting-common-features.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.26663320.insulin-degludec-does-not-increase-antibody.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.26720250.treatment-intensification-with-insulin.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.26916450.basal-insulin-initiation-in-primary-vs.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.27060930.efficacy-and-safety-of-liraglutide-versus.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.27181070.insulin-degludec-insulin-aspart-in-japanese.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.27193270.liraglutide-3-0-mg-for-weight-management-a.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.27412570.patient-level-predictors-of-achieving-early.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.27482610.effects-of-liraglutide-3-0-mg-on-weight-and-risk.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.28055230.improved-postprandial-glycemic-control-with.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.28165180.faster-acting-insulin-aspart-provides-faster.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.28526920.effects-of-semaglutide-on-beta-cell-function-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29063510.timing-of-insulin-injections-adherence-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29246950.efficacy-and-safety-of-once-weekly-semaglutide.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29279300.no-evidence-of-increase-in-calcitonin.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29316130.efficacy-and-safety-of-fast-acting-insulin-aspart.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29322610.safety-and-efficacy-of-once-weekly-semaglutide-vs.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29500310.safety-and-convenience-of-once-weekly-somapacitan.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29505680.impact-of-hemophilia-b-on-quality-of-life-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29687620.semaglutide-as-a-therapeutic-option-for-elderly.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29726070.a-comparative-analysis-of-heterogeneity-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29953740.liraglutide-decreases-hepatic-inflammation-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31595670.neurologypsychological-function-in-children-with.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31729990.heart-failure-with-insulin-degludec-versus.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32003590.increased-time-in-range-and-fewer-missed-bolus.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32107930.the-benefit-of-insulin-degludec-liraglutide.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32595770.efficacy-and-safety-evaluation-of-human-growth.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32910490.a-review-of-glp-1-receptor-agonists-in-type-2.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32971040.effects-of-once-weekly-subcutaneous-semaglutide.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32975890.switching-between-glp-1-receptor-agonists-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33072380.effect-of-intradialytic-progressive-resistance.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33132510.switching-between-glucagon-like-peptide-1.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33269530.the-effect-of-semaglutide-2-4-mg-once-weekly-on.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33439580.the-evidence-for-oral-semaglutide-in-type-2.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33500640.long-term-outcomes-of-previously-treated-adult.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33864240.population-pharmacokinetics-and-pharmacodynamics.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34016120.surrogate-endpoint-evaluation-using-data-from-one.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34154020.prevalence-of-atherosclerotic-cardiovascular.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34438400.safety-tolerability-pharmacokinetics-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34472680.associations-of-weight-loss-with-obesity-related.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34610450.structure-identification-of-circulating.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.35752730.initiating-or-switching-to-insulin.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.36542260.once-weekly-semaglutide-use-in-type-2-diabetes.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.36631720.pharmacokinetic-and-pharmacodynamic.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.36651820.the-rationale-design-and-baseline-data-of-flow.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.36655300.two-year-effect-of-semaglutide-2-4-mg-on-control.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.36775980.a-cross-sectional-study-of-the-prevalence-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.36781820.liraglutide-changes-postprandial-responses-of-gut.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.38200500.coverage-of-education-and-training-of-traumatic.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.38310920.pcsk9-inhibition-with-orally-administered.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.38368660.insights-from-an-advisory-board-facilitating.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.38679910.frequency-of-hypoglycaemia-with-basal-insulin.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.38698650.effect-of-semaglutide-2-4-mg-on-physical.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39159940.ten-year-progression-of-obesity-related.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39226070.psychiatric-safety-of-semaglutide-for-weight.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40482670.once-weekly-icosema-versus-multiple-daily-insulin.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.12145241.pharmacokinetics-pharmacodynamics-safety-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.14617231.twice-daily-biphasic-insulin-aspart-improves.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.15089801.reduced-postprandial-glycaemic-excursion-with.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.15628811.the-12-month-efficacy-and-safety-of-insulin.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.16681561.insulin-detemir-under-steady-state-conditions-no.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.17227321.insulin-detemir-compared-with-nph-insulin-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.17850471.parental-preference-of-prandial-insulin-aspart.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.19131571.porcine-marginal-mass-islet-autografts-resist.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.19210701.safety-and-effectiveness-of-biphasic-insulin.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.19527481.an-exploratory-study-of-the-effect-of-using.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.20332351.switching-to-once-daily-liraglutide-from.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.21700561.mild-renal-impairment-and-the-efficacy-and-safety.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.21700771.prolonged-half-life-and-preserved-enzymatic.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.22589391.the-effects-of-13-wk-of-liraglutide-treatment-on.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.22594461.insulin-degludec-four-times-lower.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.22726241.ultra-long-acting-insulin-degludec-has-a-flat-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.24103141.safety-of-once-daily-insulin-detemir-in-patients.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.24124961.a-novel-insulin-combination-of-insulin-degludec.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.24757241.response-to-comment-on-khunti-et-al-clinical.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.25275271.leader-3-lipase-and-amylase-activity-in-subjects.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.25492401.hypoglycemia-and-risk-of-cardiovascular-disease.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.26121451.patients-achieving-good-glycemic-control-hba1c.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.26238041.investigating-the-evidence-of-the-real-life.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.26574791.comparison-of-the-long-term-effects-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30466191.mealtime-fast-acting-insulin-aspart-versus.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30603311.insulin-degludec-in-a-simple-or-stepwise.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31011711.favorable-pharmacokinetics-in-hemophilia-b-for.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31168921.incorporating-and-interpreting-regulatory.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31249981.eptacog-alfa-activated-is-physically-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31450961.recommendations-for-improving-clinical-trial.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31704161.cardiovascular-risk-and-the-implications-for.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31860471.what-is-the-evidence-for-beneficial-effects-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32132141.safety-of-liraglutide-in-type-2-diabetes-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32139381.efficacy-and-safety-of-liraglutide-3-0-mg-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32269181.long-term-efficacy-and-safety-of-two-doses-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32327501.factor-viii-activity-and-bleeding-risk-during.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32740121.long-acting-glp-1ras-an-overview-of-efficacy.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32910491.an-overview-of-the-once-weekly-glp-1-receptor.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33115821.superior-weight-loss-with-once-weekly-semaglutide.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33151791.patient-initiation-and-maintenance-of-glp-1-ras.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33307881.the-role-of-growth-hormone-device-optimization-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33595901.efficacy-and-safety-of-the-fixed-ratio.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33657881.diabetes-and-metabolic-drivers-of-trained.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33721211.all-cause-and-cardiovascular-mortality-among.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33764641.prototype-of-an-evidence-based-tool-to-aid.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33807461.hepatic-stellate-cell-activation-and-inactivation.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33853351.association-between-genetic-variation-in-blood.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34775881.managing-the-gastrointestinal-side-effects-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.35014161.the-metabolic-triad-of-non-alcoholic-fatty-liver.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.35199581.clinical-and-economic-impact-of-primary.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.35838551.misalignment-among-adolescents-living-with.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.36056351.impact-of-semaglutide-on-high-sensitivity.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.36181471.liraglutide-for-weight-management-in-children-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.36651161.somapacitan-in-children-born-small-for.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.37622681.semaglutide-in-patients-with-heart-failure-with.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.37748181.once-weekly-insulin-icodec-with-dosing-guide-app.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.37952131.semaglutide-and-cardiovascular-outcomes-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.37993201.semaglutide-in-patients-with-obesity-and-heart.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.38375061.evaluating-patient-and-provider-preferences-for-a.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.38572481.noninterventional-study-assessing-joint-health-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.38599221.semaglutide-versus-placebo-in-people-with.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.38985161.efficacy-and-safety-of-oral-semaglutide-vs.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39099801.concizumab-prophylaxis-in-persons-with-hemophilia.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39192531.elucidating-the-role-of-weight-loss-and-glycaemic.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39374601.continuous-glucose-monitoring-based-metrics-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39488821.pharmacokinetic-properties-of-a-once-weekly.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39533311.a-time-trade-off-study-in-the-uk-canada-and-the.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39948761.safety-profile-of-semaglutide-versus-placebo-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.21421802.evidence-linking-hypoglycemic-events-to-an.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.22288732.addition-of-liraglutide-in-patients-with-type-2.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.22584132.sequential-intensification-of-metformin-treatment.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.23710902.insulin-degludec-improves-glycaemic-control-with.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.23757032.safety-and-effectiveness-of-bolus-insulin-aspart.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.23877982.clinical-inertia-in-people-with-type-2-diabetes.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.23899102.evidence-supporting-an-association-between.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.24812432.comparison-of-insulin-degludec-insulin-aspart-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.24843632.insulin-degludec-in-japanese-patients-with-type-1.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.25124362.glucose-lowering-effect-of-insulin-degludec-is.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.25323312.is-insulin-the-most-effective-injectable.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.25475122.semaglutide-a-once-weekly-human-glp-1-analog.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.26260082.bioavailability-of-insulin-detemir-and-human.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.26592732.treatment-intensification-with-an-insulin.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.26597252.liraglutide-in-type-2-diabetes-mellitus-clinical.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.26612062.lower-rates-of-hypoglycemia-during-maintenance.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.26679282.impact-of-diabetes-duration-on-achieved.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.26903552.is-safety-of-childhood-growth-hormone-therapy.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.27182042.combination-therapy-with-liraglutide-and-insulin.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.27274772.leader-7-cardiovascular-risk-profiles-of-us-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.27493132.efficacy-and-safety-of-liraglutide-added-to.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.27506222.efficacy-and-safety-of-liraglutide-added-to.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.27589252.safety-and-efficacy-of-insulin.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30938762.reductions-in-insulin-resistance-are-mediated.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31040652.health-related-quality-of-life-and-treatment.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31124272.safety-analysis-of-rfviia-with-emicizumab-dosing.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31148392.prophylactic-administration-of-glycopegylated.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31259302.haemocare-the-first-international.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31444162.subcutaneous-concizumab-prophylaxis-in-hemophilia.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31549312.steady-state-plasma-concentrations-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31608552.impact-of-baseline-characteristics-and-beta-cell.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31903692.semaglutide-sustain-and-pioneer-reduces.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32208682.identification-of-binding-sites-on-human-serum.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32740122.long-acting-glp-1-receptor-agonists-findings-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32869682.vaginal-health-insights-views-attitudes.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.3287182.monomeric-insulins-obtained-by-protein.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32910492.cardiovascular-safety-outcomes-of-once-weekly.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32998732.effects-of-semaglutide-on-risk-of-cardiovascular.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33000382.considerations-for-insulin-treated-type-2.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33290752.adherence-to-growth-hormone-therapy-guidelines-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33390422.efficacy-and-safety-of-fast-acting-insulin-aspart.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34852662.development-of-an-insulin-pen-is-a.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.35874312.the-potential-of-glp-1-receptor-agonists-in-type.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.36106652.rationale-and-design-of-the-phase-3a-development.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.36476232.understanding-the-risk-of-developing.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.36644202.semaglutide-treatment-attenuates-vessel.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.36710452.higher-derived-time-in-range-with-ideglira-versus.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.36789682.once-weekly-semaglutide-use-in-patients-with-type.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.36796312.patterns-of-new-glucagon-like-peptide-1-receptor.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.36821002.understanding-treatment-burden-in-hemophilia.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.36891522.prevalence-of-selected-bleeding-and-thrombotic.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.36932262.effect-of-various-dosing-schedules-on-the.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.36946442.medical-journey-of-patients-with-mild-cognitive.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.36995872.weekly-somapacitan-in-gh-deficiency-4-year.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.38985162.efficacy-and-safety-of-oral-semaglutide.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39118222.real-world-safety-profile-of-once-weekly.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39211962.systemic-inflammation-and-health-outcomes-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39222642.semaglutide-versus-placebo-in-patients-with-heart.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39468412.anti-obesity-treatment-preferences-of-healthcare.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39494972.the-haemophilia-joint-health-score-for-the.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39703112.improved-glycaemic-control-in-people-with-type-2.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39735352.awareness-and-perceptions-towards-the-role-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39849892.action-teens-global-survey-t-252-rkiye-report.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39963742.noninvasive-tests-and-diagnostic-pathways-to-mash.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40102962.efficacy-and-hypoglycemia-profile-of-once-weekly.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.14984453.the-post-prandial-state-in-type-2-diabetes-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.15209873.recombinant-fviia.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.15735183.continuous-subcutaneous-insulin-infusion-csii.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.17372153.liraglutide-a-long-acting-human-glucagon-like.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.17593233.overnight-csii-as-supplement-to-oral-antidiabetic.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.17888133.efficacy-safety-and-lack-of-immunogenicity-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.18435773.patient-reported-rating-of-gastrointestinal.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.18541123.tolerability-pharmacokinetics-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.18607693.effect-of-ethylenediamine-on-chemical-degradation.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.20590743.insulin-detemir-is-a-fully-efficacious-low.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.21205123.efficacy-and-safety-of-insulin-detemir-once-daily.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.21599553.impact-of-weight-gain-on-outcomes-in-type-2.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.22193143.efficacy-of-antihyperglycemic-therapies-and-the.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.22226053.liraglutide-short-lived-effect-on-gastric.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.22234463.glp-1-receptor-agonists-and-the-thyroid-c-cell.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.22338093.the-human-glp-1-analog-liraglutide-and-the.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.22985213.long-term-efficacy-and-safety-comparison-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.23163663.safety-and-efficacy-of-liraglutide-in-patients.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.23577643.effect-of-insulin-degludec-versus-sitagliptin-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.23715753.low-volume-insulin-degludec-200-units-ml-once.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.23860823.safety-and-effectiveness-of-biphasic-insulin.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.24057153.insulin-degludec-is-not-associated-with-a-delayed.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.24224883.insulin-therapy-for-the-treatment-of-type-1.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29793353.developing-planning-and-conducting-an-interim.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29907893.semaglutide-s-c-once-weekly-in-type-2-diabetes.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30024643.in-silico-and-in-vitro-immunogenicity-assessment.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30026333.a-26-week-randomized-controlled-trial-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30246473.cardiovascular-disease-prevalence-and-risk-factor.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30254423.glycopegylated-recombinant-factor-ix-for.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30568523.continuous-infusion-of-recombinant-activated.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30603293.a-comparison-of-ideg-iasp-versus-idet-iasp-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30780853.liraglutide-effect-and-action-in-diabetes-lead.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30869183.efficacy-and-safety-of-insulin-degludec-insulin.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30974973.patient-reported-outcomes-from-a-randomized.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31609513.concizumab-promotes-haemostasis-via-a-tissue.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31858673.benefits-of-insulin-degludec-liraglutide-are.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31975753.clinical-use-of-ideglira-initiation-to-titration.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31984443.risk-of-hypoglycaemia-with-insulin-degludec.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32022863.once-weekly-somapacitan-is-effective-and-well.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32213703.semaglutide-lowers-body-weight-in-rodents-via.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32227613.semaglutide-improves-health-related-quality-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32441473.semaglutide-2-4-mg-for-the-treatment-of-obesity.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.35246453.noonan-syndrome-improving-recognition-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.35287493.development-and-validation-of-the-diabetes-pen.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.35290453.long-term-efficacy-and-safety-of-subcutaneous.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.35373893.efficacy-and-safety-of-oral-semaglutide-by.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.37935463.greater-time-spent-with-hba1c-less-than-7-0-with.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.38048543.occurrence-of-gastrointestinal-adverse-events.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.38088483.real-world-study-of-the-concomitant-use-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.38291203.cost-effectiveness-of-weight-management.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.38368603.effective-growth-hormone-replacement-with.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.38416593.semaglutide-and-cardiovascular-outcomes-by.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.38516633.nonacog-beta-pegol-prophylaxis-in-children-with.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.38587233.semaglutide-in-patients-with-obesity-related.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39052163.pioneer-real-sweden-a-multicentre-prospective.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39081763.effects-of-once-weekly-semaglutide-on-kidney.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39089293.efficacy-and-safety-of-once-weekly-semaglutide.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40402403.time-to-treatment-intensification-with.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40555703.pioneer-real-spain-a-multicentre-prospective.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40843773.efficacy-and-safety-of-oral-semaglutide-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40848513.efficacy-safety-and-outcomes-of-growth-hormone.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40853353.cost-effectiveness-of-insulin-icodec-for-the.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40980163.proteomic-signatures-reflect-effects-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.8721773.soluble-fatty-acid-acylated-insulins-bind-to.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.10934454.symptomatic-and-counterregulatory-hormonal.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.11194244.efficacy-safety-and-pump-compatibility-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.11978684.immune-responses-to-insulin-aspart-and-biphasic.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.12630974.comparative-effect-of-human-soluble-insulin-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.14578244.insulin-detemir-is-characterized-by-a-consistent.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.15111514.a-direct-efficacy-and-safety-comparison-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.15717874.pharmacokinetic-profiles-of-biphasic-insulin.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.15855574.a-double-blind-randomized-dose-response-study.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.17391154.albumin-bound-basal-insulin-analogues-insulin.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.19821654.once-daily-initiation-with-biphasic-insulin.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.20002084.effect-of-renal-impairment-on-the.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.20007944.hypoglycemia-in-type-1-diabetic-pregnancy-role.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.20671294.effect-of-three-different-injection-sites-on-the.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29912994.a-clinical-overview-of-once-weekly-glucagon-like.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30137664.a-randomized-trial-of-safety-pharmacokinetics.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30259644.fast-acting-insulin-aspart-versus-insulin-aspart.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30402994.long-term-safety-and-efficacy-of-turoctocog-alfa.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30461134.utility-valuation-of-health-states-for.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30566004.effects-of-liraglutide-on-cardiovascular-outcomes.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30656284.reagent-specific-underestimation-of-turoctocog.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31034184.liraglutide-in-children-and-adolescents-with-type.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31115094.haemophilia-experiences-results-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31167654.cardiovascular-risk-reduction-with-once-weekly.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31305924.treatment-of-children-with-gh-in-the-united.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33750044.relationship-between-oral-semaglutide-tablet.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33813844.relationship-between-blood-pressure-and-incident.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33875484.a-randomized-open-label-comparison-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33946944.genetic-evidence-supporting-fibroblast-growth.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34123394.a-novel-decision-model-to-predict-the-impact-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34212484.response-to-the-letter-from-horowitz-et-al-to-the.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34293304.efficacy-and-safety-of-once-weekly-semaglutide.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34319564.absence-of-qtc-prolongation-with-sodium.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34572384.modelling-nonalcoholic-steatohepatitis-in-vivo-a.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34896604.management-of-growth-failure-and-other-endocrine.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34913834.invitro-drug-drug-interactions-of-decitabine-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34957654.effect-of-upper-gastrointestinal-disease-on-the.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.35112504.efficacy-and-safety-of-oral-semaglutide-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.35229024.treatment-with-glucagon-like-peptide-1-receptor.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.37597724.the-immunogenicity-safety-and-efficacy-of-n8-gp.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.37685604.systematic-literature-review-shows-gaps-in-data.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.37863084.once-weekly-insulin-icodec-versus-once-daily.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.38066644.gene-expression-signatures-predict-first-year.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.38112484.artificial-intelligence-scoring-of-liver-biopsies.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.38291654.safety-of-recombinant-activated-factor-vii-for.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.38332544.action-apac-understanding-perceptions-attitudes.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.38380954.continuous-glucose-monitoring-based-metrics-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.38819334.semaglutide-and-nt-probnp-in-obesity-related.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39387634.development-and-validation-of-the-child.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39485624.burden-of-current-insulin-therapy-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39677374.utilizing-artificial-intelligence-for-the.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39896054.effect-of-glucagon-like-peptide-1-receptor.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39950364.factor-viii-activity-and-factor-viii-inhibitors.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40279144.high-dose-semaglutide-up-to-16-mg-in-people.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40324364.somapacitan-is-effective-and-well-tolerated-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40341754.macrovascular-and-microvascular-complications-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40377834.healthcare-resource-utilization-and-costs-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40465144.insights-on-hospitalisations-from-160-the-phase.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40608494.rationale-design-and-baseline-characteristics-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40720214.ease-of-use-of-the-reusable-duratouch-pen.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.10332685.improved-postprandial-glycemic-control-with.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.10379635.comparative-pharmacokinetics-and-pharmacodynamics.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.10928235.improved-postprandial-glycaemic-control-with.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.24843715.insulin-degludec-compared-with-insulin-glargine.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.24888255.distinct-prandial-and-basal-glucose-lowering.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.25179915.a-review-of-the-pharmacological-properties-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.25387855.insulin-degludec-improves-long-term-glycaemic.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.25869785.the-glp-1-receptor-agonist-liraglutide-improves.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.26088815.the-distinct-prandial-and-basal-pharmacodynamics.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.26308095.discovery-of-the-once-weekly-glucagon-like.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.26435365.twice-daily-insulin-degludec-insulin-aspart.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.26744025.efficacy-and-safety-of-liraglutide-3-0-mg-for.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.27098525.a-multinational-randomized-open-label.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.27233285.understanding-post-prandial-hyperglycemia-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.27350545.clinical-effectiveness-of-liraglutide-in-type-2.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.27381275.efficacy-and-safety-of-switching-from-sitagliptin.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.27600385.development-of-insulin-detemir-insulin-aspart.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.28249135.semaglutide-and-cardiovascular-outcomes-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.28306165.is-gh-dosing-optimal-in-female-patients-with.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.28417535.rates-of-hypoglycaemia-are-lower-in-patients.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.28522645.real-life-gh-dosing-patterns-in-children-with.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.28556675.a-new-modeling-approach-allowing-prediction-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.28643425.insulin-degludec-liraglutide-ideglira-was.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30392095.liraglutide-and-glycaemic-outcomes-in-the-leader.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30664825.fixing-postinfusion-monitoring-assay-experiences.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30785655.fixed-ratio-combination-of-insulin-degludec-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30793465.lower-rates-of-cardiovascular-events-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30850995.cardiovascular-safety-and-lower-severe.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31001865.clinical-benefits-of-switching-to-insulin.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31069935.fast-acting-insulin-aspart-in-people-with-type-2.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31076415.efficacy-and-safety-of-fast-acting-insulin-aspart.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31294905.a-field-study-evaluating-the-activity-of-n8-gp-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31385425.ideglira-improves-patient-reported-outcomes-while.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31397845.switching-to-degludec-from-other-basal-insulins.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31407845.superior-efficacy-with-a-fixed-ratio-combination.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31423685.superior-hba1c-control-with-the-fixed-ratio.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31517435.clinical-evaluation-of-bleeds-and-response-to.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31572035.correlations-between-patient-reported-outcomes.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31616195.hemophilia-and-sexual-health-results-from-the.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31639805.evaluation-of-n8-gp-activity-using-a-one-stage.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31658975.redefining-hypoglycemia-in-clinical-trials.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31809565.an-overview-of-turoctocog-alfa-pegol-n8-gp.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31917835.once-weekly-somapacitan-vs-daily-gh-in-children.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32009825.population-pharmacokinetic-modeling-of-on-demand.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32314525.validation-of-distinct-type-2-diabetes-clusters.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34254445.the-impact-of-covid-19-on-obesity-services-across.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34289755.effect-of-oral-semaglutide-on-the.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34417265.a-hundred-years-of-insulin-innovation-when.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34463425.efficacy-and-safety-of-liraglutide-in-type-1.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34524005.continuous-glucose-monitoring-sensor-glucose.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34558105.cardiovascular-risk-factors-early-in-the-course.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34584405.clinicians-feedback-on-patient-carer-experience.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34622555.weight-loss-interventions-and-nonalcoholic-fatty.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.35031585.etavopivat-a-pyruvate-kinase-activator-in-red.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.35245205.outcomes-in-growth-hormone-treated-noonan.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.35791625.ease-of-use-and-acceptability-of-the-novel.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.36216945.two-year-effects-of-semaglutide-in-adults-with.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.38468125.use-of-once-daily-oral-semaglutide-and-associated.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.38569055.association-between-treatment-adherence-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.38640825.pediatric-growth-hormone-deficiency.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.38731185.efficacy-and-safety-analyses-of-recombinant.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39217565.atrial-fibrillation-and-semaglutide-effects-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39217575.semaglutide-effects-on-cardiovascular-outcomes-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39937035.pharmacokinetic-properties-of-once-weekly-insulin.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.12610006.insulin-detemir-is-associated-with-more.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.12675646.a-randomized-trial-of-insulin-aspart-with.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.15642076.lower-within-subject-variability-of-fasting-blood.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.15677776.initiating-insulin-therapy-in-type-2-diabetes-a.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.15729576.comparison-of-the-effects-on-glucose-and-lipid.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.15842516.insulin-aspart-improves-meal-time-glycaemic.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.16236036.pharmacokinetics-of-insulin-aspart-in-obesity.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.16842476.insulin-detemir-lowers-the-risk-of-hypoglycaemia.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.17697056.premixed-insulin-treatment-for-type-2-diabetes.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.17979896.lower-risk-of-hypoglycemia-with-insulin-detemir.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.18034606.comparison-of-in-vitro-stability-for-insulin.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.18269636.biphasic-insulin-aspart-30-treatment-improves.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.18588656.practical-strategies-to-improve-treatment-of-type.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.18726086.evaluation-of-insulin-antibodies-and-placental.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.19751116.improved-glycaemic-control-with-biasp-30-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.19930006.weight-loss-with-liraglutide-a-once-daily-human.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.21114606.co-administration-of-liraglutide-with-insulin.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.21175436.influence-of-hepatic-impairment-on.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.21219436.pharmacokinetics-and-pharmacodynamics-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.21340616.the-once-daily-human-glucagon-like-peptide-1.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.21653676.cardiovascular-safety-of-liraglutide-assessed-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.21883806.achieving-a-clinically-relevant-composite-outcome.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.22150786.improved-health-status-with-insulin-degludec.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.22660026.comparison-of-a-soluble-co-formulation-of-insulin.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.28556616.fast-acting-insulin-aspart-in-japanese-patients.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.28672316.effect-of-insulin-degludec-vs-insulin-glargine.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.28946756.day-to-day-and-within-day-variability-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29205786.pharmacokinetics-and-tolerability-of-semaglutide.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29205856.use-and-effectiveness-of-a-fixed-ratio.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29397376.semaglutide-versus-dulaglutide-once-weekly-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29451706.the-co-formulation-of-insulin-degludec-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29748996.exposure-response-analysis-for-evaluation-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29758126.abrogating-fibrinolysis-does-not-improve-bleeding.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29802636.the-effect-of-basal-bolus-therapy-varies-with.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29892986.effects-of-liraglutide-on-gallbladder-emptying-a.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30047216.impact-on-hba1c-and-body-weight-of-switching-from.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30058866.a-systematic-review-of-the-safety-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30112856.evaluating-the-thrombin-generation-profiles-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30565096.safety-and-pharmacokinetics-of-single-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30566006.effects-of-liraglutide-versus-placebo-on.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30663196.pleiotropic-effects-of-liraglutide-in-patients.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30746556.elucidating-the-mechanism-of-absorption-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30817066.once-weekly-prophylaxis-with-glycopegylated.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30865526.greater-combined-reductions-in-hba1c-1-0-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30879256.switching-real-world-diabetes-patients-to.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32558236.an-overview-of-the-pathfinder-clinical-trials.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32606716.safety-and-efficacy-of-turoctocog-alfa-in-the.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32618386.cardiovascular-and-renal-outcomes-by-baseline.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32815436.clinical-review-of-the-efficacy-and-safety-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33052536.quality-of-life-and-utility-values-for.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33134776.nonacog-beta-pegol-n9-gp-in-hemophilia-b-first.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33354706.management-of-type-2-diabetes-with-oral.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33433896.psychometric-validation-of-the-growth-hormone.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33504496.changes-in-albuminuria-predict-cardiovascular-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33625476.effect-of-subcutaneous-semaglutide-vs-placebo-as.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33626236.food-intake-rather-than-blood-glucose-levels.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33830626.duration-of-type-2-diabetes-does-not-appear-to.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33969456.clinical-pharmacokinetics-of-oral-semaglutide.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34570916.randomised-clinical-trial-semaglutide-versus.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34791736.zero-incidence-of-factor-viii-inhibitors-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34811856.clinical-outcomes-after-joint-surgery-in-patients.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.35333446.benefits-of-weight-loss-of-10-or-more-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.36062966.weekly-somapacitan-is-effective-and-well.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.36514266.effects-of-once-weekly-subcutaneous-semaglutide.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.36637246.association-between-body-mass-index-weight-loss.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.36691306.integrating-semaglutide-into-obesity-management.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.36789676.nonalcoholic-fatty-liver-disease-from-a-primary.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.37450196.fast-acting-insulin-aspart-in-patients-with-type.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.37605636.effect-of-semaglutide-2-4-mg-once-weekly-on.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.37646676.phase-3-trial-of-concizumab-in-hemophilia-with.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.37752566.ceramides-are-decreased-after-liraglutide.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.38142846.frontier1-a-partially-randomized-phase-2-study.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.38332756.semaglutide-2-4-mg-clinical-outcomes-in-patients.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.38808476.a-phase-1-randomized-double-blind.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40351776.gaps-in-masld-mash-education-a-quantitative-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40874386.glycaemic-control-after-connected-insulin-pen.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.7895946.the-potential-immunogenicity-of-human-insulin-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.11872677.albumin-binding-of-acylated-insulin-nn304-does.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.11874927.comparison-of-insulin-aspart-with-buffered.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.12027927.premixed-insulin-aspart-30-vs-premixed-human.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.15277417.the-effect-of-liraglutide-a-long-acting.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.15359587.the-mechanism-of-protraction-of-insulin-detemir.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.21222567.neurologyprotective-properties-of-glp-1.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.21355967.one-year-of-liraglutide-treatment-offers.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.21450987.liraglutide-treatment-is-associated-with-a-low.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.21550957.comparison-of-2-intensification-regimens-with.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.22862847.weight-change-with-liraglutide-and-comparator.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.23094597.insulin-analogues-in-children-with-type-1.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.23337147.effect-of-baseline-glycosylated-hemoglobin-a1c-on.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.23488447.predictors-of-achieving-hba-1c-7-and-no.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.23557077.superior-glycaemic-control-with-once-daily.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.24499517.initiation-of-once-daily-insulin-detemir-is-not.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.25013997.a-reversible-albumin-binding-growth-hormone.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.28124817.safety-and-efficacy-of-ideglira-titrated-once.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.28349387.effect-of-semaglutide-on-the-pharmacokinetics-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.28473337.impact-of-liraglutide-on-amylase-lipase-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.28672317.effect-of-insulin-degludec-vs-insulin-glargine.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.28786547.safety-and-efficacy-of-semaglutide-once-weekly-vs.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29903847.hypoglycemia-cardiovascular-outcomes-and-death.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29912997.clinical-efficacy-of-once-weekly-glucagonlike.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29947247.cardiovascular-outcomes-in-patients-who.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30210757.practical-aspects-of-extended-half-life-products.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30248217.once-weekly-prophylaxis-with-40-iu-kg-nonacog.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30354517.liraglutide-reduces-cardiovascular-events-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33532617.use-and-perception-of-telemedicine-in-people-with.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33595677.current-and-future-therapies-for-type-1-diabetes.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33667417.semaglutide-2-4-mg-once-a-week-in-adults-with.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33673227.temporal-development-of-dyslipidemia-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33710717.oral-semaglutide-improves-postprandial-glucose.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33899627.impact-of-postmenopausal-vaginal-discomfort-on.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34148677.commemorating-insulin-s-centennial-engineering.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39030946.disease-and-treatment-burden-of-patients-with.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39082206.effect-of-oral-semaglutide-on-energy-intake.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.36623517.insulin-degludec-versus-insulin-detemir-both-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.36630047.once-weekly-subcutaneous-semaglutide-2-4-mg.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.36691307.exploring-the-wider-benefits-of-semaglutide.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.36700417.safety-and-tolerability-of-semaglutide-across-the.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.37137527.study-design-and-baseline-profile-for-adults-with.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.37264767.evaluating-potential-predictors-of-weight-loss.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.37620807.effect-of-semaglutide-on-major-adverse.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.37635157.semaglutide-in-hfpef-across-obesity-class-and-by.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.37989717.efficacy-and-safety-of-semaglutide-2-4-mg.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39119627.perceptions-attitudes-and-barriers-to-effective.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39171857.initiating-or-switching-to-insulin.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39181597.semaglutide-and-cardiovascular-outcomes-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39217567.effect-of-semaglutide-on-cardiac-structure-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40122077.semaglutide-2-4-mg-long-term-clinical-outcomes-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40296897.usability-and-preference-evaluation-of-the.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40494747.the-role-potential-benefits-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40533717.modelled-weight-loss-in-an-english-population.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40711887.a-multicenter-prospective-real-world-study-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40803997.adherence-to-app-based-dose-guidance-for.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40892617.sex-differences-in-effectiveness-of-semaglutide.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.10220208.time-action-profile-of-the-soluble-fatty-acid.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.21633908.insulin-x10-revisited-a-super-mitogenic-insulin.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.22174428.dosing-rationale-for-liraglutide-in-type-2.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.22933438.insulin-degludec-insulin-aspart-administered-once.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.23199058.insulin-degludec-improves-health-related-quality.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.23323988.real-world-factors-affecting-adherence-to-insulin.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.23617228.a-randomized-trial-comparing-perinatal-outcomes.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.23687948.poor-pregnancy-outcome-in-women-with-type-1.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.23999198.effects-of-the-once-daily-glp-1-analog.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.24495158.health-status-and-hypoglycaemia-with-insulin.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.24843528.fifty-two-week-randomized-multicenter-trial-to.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.25061148.glp-1-provoked-severe-hypoglycemia-in-an.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.25180608.the-simplemix-study-with-biphasic-insulin-aspart.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.27027878.efficacy-and-safety-of-once-daily-insulin.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.27091198.filling-the-knowledge-gap-in-diabetes-management.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.27161418.rates-and-predictors-of-hypoglycaemia-in-27-585.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.27282158.pharmacokinetic-properties-of-liraglutide-as.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.27352908.improvement-in-health-related-quality-of-life-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.27378188.pharmacokinetics-tissue-distribution-excretion.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.27457238.a-review-of-insulin-dosing-formulas-for.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.27542128.glp-1-induces-barrier-protective-expression-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.27817208.liraglutide-3-0-mg-for-weight-management.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.2851598.epstein-barr-virus-nuclear-antigen-type-1.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29024408.effects-of-glucagon-like-peptide-1-receptor.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29044708.optimal-prandial-timing-of-bolus-insulin-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29912998.safety-of-once-weekly-glucagon-like-peptide-1.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29914758.specific-inhibition-of-hepatic-lactate.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30226298.worsening-of-diabetic-retinopathy-with-rapid.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30260088.health-related-quality-of-life-in-people-with.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30317158.cost-effectiveness-of-rfviia-versus-pd-apcc-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30408848.concizumab-restores-thrombin-generation-potential.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30464668.evaluation-of-bleeding-disorders-in-patients-with.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30474818.efficacy-and-safety-of-idegasp-versus-biasp-30.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30547388.investigating-the-association-between-baseline.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30788808.population-pharmacokinetics-of-semaglutide-for.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30924578.baseline-nocturnal-glucose-change-a-predictor-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30945118.effect-of-oral-semaglutide-on-the.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31394258.a-systems-pharmacokinetic-pharmacodynamic-model.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31399438.effects-of-liraglutide-compared-with-placebo-on.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31804738.rapid-progression-of-type-2-diabetes-and-related.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31960258.clinical-considerations-when-initiating-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32009288.impact-of-dose-escalation-schemes-and-drug.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32152818.plasma-polyethylene-glycol-peg-levels-reach.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32233338.a-randomized-controlled-trial-of-liraglutide-for.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32259078.inventing-liraglutide-a-glucagon-like-peptide-1.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32267058.efficacy-safety-and-cardiovascular-outcomes-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33591618.comparison-of-the-injection-site-experience-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33596938.insulin-treatment-improves-liver-histopathology.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33660198.oral-semaglutide-reduces-hba1c-and-body-weight-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33704808.low-density-lipoprotein-cholesterol-and-lifespan.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33709288.pregnancy-outcomes-in-women-receiving-growth.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33755728.effect-of-continued-weekly-subcutaneous.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34146238.improvements-in-glycemic-control-achieved-by.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34149258.exploring-why-people-with-type-2-diabetes-do-or.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34193488.changing-the-narrative-around-obesity-in-the-uk.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34387408.liraglutide-reduces-cardiac-adipose-tissue-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34413118.molecular-and-pharmacological-characterization-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34622228.levels-of-circulating-semaglutide-determine.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34622548.efficacy-and-safety-of-oral-semaglutide-by.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34676658.the-importance-of-addressing-multiple-risk.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34681038.genetically-predicted-type-2-diabetes-mellitus.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34707178.the-effect-of-fatty-diacid-acylation-of-human.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.36691308.cardiometabolic-risk-factors-efficacy-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.37016488.semaglutide-reduces-the-risk-of-major-adverse.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.37385278.oral-semaglutide-50-mg-taken-once-per-day-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.37940228.plasma-proteomics-to-identify-drug-targets-for.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.38088558.effect-of-ziltivekimab-on-determinants-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.38727678.liver-histology-is-associated-with-long-term.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.38739118.semaglutide-and-diuretic-use-in-obesity-related.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.38749508.clinical-perspectives-on-the-frequency-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.38924198.minimal-interference-of-concizumab-with-standard.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39159938.variations-in-healthcare-costs-by-body-mass-index.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39211948.cardiovascular-outcomes-with-semaglutide-by.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39699848.augmented-real-world-data-enhances-comparative.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39848268.semaglutide-in-obesity-related-heart-failure-with.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39972508.no-evidence-of-increased-hypoglycaemia-attributed.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40104568.growth-response-to-weekly-somapacitan-therapy-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40146378.once-weekly-semaglutide-versus-sodium-glucose.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40156748.the-composite-number-needed-to-treat-for.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40543068.benefit-of-semaglutide-in-symptomatic-peripheral.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.11009049.pharmacokinetics-and-pharmacodynamics-of-a.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.12873289.effect-of-the-rapid-acting-insulin-analogue.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.16235159.the-pharmacokinetic-and-pharmacodynamic.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.17115349.biphasic-insulin-aspart-given-thrice-daily-is-as.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.17392539.maternal-glycemic-control-and-hypoglycemia-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.18541709.expression-of-the-glp-1-receptor-in-mouse-rat.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.18643839.comparison-of-insulin-analogue-regimens-in-people.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.19476479.three-different-premixed-combinations-of-biphasic.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.19565569.comparison-of-insulin-detemir-and-insulin.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.20415689.obesity-does-not-influence-the-unique.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.21285389.a-new-generation-ultra-long-acting-basal-insulin.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.26179619.efficacy-and-safety-of-liraglutide-versus-placebo.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.26934259.effect-of-insulin-glargine-up-titration-vs.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.27000799.self-treated-hypoglycemia-in-type-2-diabetes.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.27059529.insulin-degludec-insulin-aspart-versus-biphasic.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.27560769.insulin-degludec-insulin-aspart-vs-biphasic.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.27736009.the-effect-of-growth-hormone-gh-replacement-on.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.27760129.efficacy-and-safety-of-once-daily-insulin.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.27804269.early-weight-loss-with-liraglutide-3-0-mg.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.28094469.immunohistochemical-assessment-of-glucagon-like.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.28205039.a-pooled-analysis-of-clinical-pharmacology-trials.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.28266779.effects-of-once-weekly-semaglutide-on-appetite.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.28356319.fast-acting-insulin-aspart-improves-glycemic.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30014589.efficacy-and-safety-of-a-fixed-combination-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30168709.long-acting-human-growth-hormone-analogue-by.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30284349.cardiovascular-safety-of-oral-semaglutide-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30525289.factor-viii-with-a-237-amino-acid-b-domain-has-an.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30780809.improve-observational-study-of-biphasic-insulin.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30888109.reach-a-programme-for-improving-care-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31040709.cardiovascular-risks-in-type-2-diabetes-and-the.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31093929.the-effect-of-food-intake-on-the-pharmacokinetics.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31411779.mediation-analysis-of-time-to-event-endpoints.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31572039.thrombotic-events-with-recombinant-activated.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31606899.clinical-utility-and-impact-of-the-use-of-the.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31667789.fast-acting-insulin-aspart-a-review-of-its.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34133769.the-contributions-of-insulin-to-science-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34142429.use-of-once-weekly-semaglutide-in-patients-with.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34387409.a-clinical-overview-of-non-alcoholic-fatty-liver.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34865209.predictive-modeling-identifies-total-bleeds-at.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34903039.effect-of-the-glucagon-like-peptide-1-receptor.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.36599459.real-world-use-of-once-weekly-semaglutide-in-type.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.36812069.burden-of-illness-associated-with-overweight-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.37037699.in-vitro-effects-of-combining-mim8-with-factor.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.37074669.polycystic-ovary-syndrome-and-obesity-a.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.37745159.mim8-a-novel-factor-viiia-mimetic-bispecific.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.38188279.prognostic-utility-of-fibrosis-4-index-for-risk.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.38333899.developments-in-the-management-of-growth-hormone.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.38792469.rationale-for-the-potential-use-of-recombinant.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.38969919.investigating-the-bioavailability-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39115159.a-comparison-of-the-safety-and-effectiveness-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39316289.pioneer-real-uk-a-multi-centre-prospective.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39412509.semaglutide-2-4-mg-in-participants-with-metabolic.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39609879.similar-weight-loss-with-semaglutide-regardless.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.8365089.action-profile-of-the-rapid-acting-insulin.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.NN190a3854969.a-new-basal-insulin-option-the-begin-trials-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.NN190a3854e59.a-reproducibility-rule-for-choosing-the-number-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.NN190a3855413.are-there-differences-in-the-efficacy-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.NN190a3855693.cardiovascular-outcome-trials-in-type-2-diabetes.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.NN190a3855b45.consequences-of-weight-gain-associated-with.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.NN190a38560b5.bmi-and-risk-of-obesity-related-conditions-in-a.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.NN190a38565d2.insulin-detemir-and-its-unique-mechanism-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.NN190a3856941.patient-directed-titration-for-achieving-glycemic.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.NN190a38572d9.scale-sleep-apnoe.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.NN190a3857571.semaglutide-2-4-mg-once-weekly-reduces-energy.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.NN1978e22f56c.safety-tolerability-pharmacokinetics-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.NN1978dffa928.amycretin-a-novel-unimolecular-glp-1-and-amylin.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.NN199be2828c3.impact-of-body-mass-index-and-comorbidities-on.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.NN195669358dc.tackling-the-complexity-of-obesity-in-the-us.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.NN1958ab77dad.a-plain-language-summary-of-the-phase-3-explorer7.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.NN195d341f29a.oral-semaglutide-and-cardiovascular-outcomes-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.NN1919844ae0a.driving-improvement-of-diagnosis-and-awareness-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.NN191e128d392.liraglutide-for-children-6-to-12-years-of-age.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.NN1995703685d.oral-semaglutide-at-a-dose-of-25-mg-in-adults.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.NN195f552a2b9.phyox3-nedosiran-long-term-safety-and-efficacy.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.NN196af79197b.pharmacokinetic-properties-of-once-weekly-insulin.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.NN1942bde2c91.proteomic-changes-upon-treatment-with-semaglutide.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.16707410.an-open-label-parallel-group-study-investigating.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.17381500.comparison-of-insulin-detemir-and-insulin.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.18204830.a-randomised-52-week-treat-to-target-trial.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.18715200.reduced-weight-gain-with-insulin-detemir-compared.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.19187170.initiating-insulin-therapy-with-or-switching.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.19210140.efficacy-and-safety-of-biphasic-insulin-aspart.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.19487640.biphasic-insulin-aspart-30-70-pharmacokinetics.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.19503780.use-of-short-acting-insulin-aspart-in-managing.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.19737980.absence-of-qtc-prolongation-in-a-thorough-qt.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.22485010.design-of-the-novel-protraction-mechanism-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.22851600.efficacy-and-safety-of-switching-from-the-dpp-4.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30072400.the-impact-of-liraglutide-on-diabetes-related.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30139820.growth-hormone-therapy-in-children-born-small-for.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30171440.optimized-workflow-for-selecting-peptides-for.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30188610.obesity-in-the-global-haemophilia-population.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30221550.towards-a-better-understanding-of-postprandial.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30362250.day-to-day-fasting-self-monitored-blood-glucose.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30508430.effect-of-liraglutide-on-cardiovascular-outcomes.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30537180.a-randomized-multicentre-trial-evaluating-the.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30552800.a-comparative-effectiveness-study-of-degludec-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30705500.effect-of-insulin-degludec-versus-insulin.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30761720.superior-efficacy-of-insulin-degludec-liraglutide.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30851070.duration-of-diabetes-and-cardiorenal-efficacy-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34704120.a-higher-non-severe-hypoglycaemia-rate-is.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34748170.improved-glycemic-control-observed-in-children.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34957480.multicomponent-plasmid-protects-mice-from.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.36934740.semaglutide-2-4-mg-once-weekly-in-patients-with.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.37017470.increased-derived-time-in-range-is-associated.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.37120480.evaluating-the-long-term-cost-effectiveness-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.37219410.perspectives-of-patients-care-partners-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.37364590.efficacy-and-safety-of-co-administered.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39493440.patients-with-growth-related-disorders-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39665530.pharmacological-characteristics-of-once-weekly.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40484340.systemic-inflammation-and-the-risks-of-adverse.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40579810.impact-of-semaglutide-2-4-mg-on-healthcare.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40618200.association-between-weight-loss-and-reproductive.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40629530.long-acting-pyy3-36-analogue-with-semaglutide-for.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40742780.continuous-glucose-monitoring-metrics-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.26662611.improvement-in-glycated-haemoglobin-evaluated-by.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.26886441.hypoglycemia-event-rates-a-comparison-between.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.27182031.efficacy-and-safety-of-once-daily-insulin.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.27311491.once-daily-liraglutide-versus-lixisenatide-as.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.27376711.efficacy-and-safety-of-liraglutide-compared-to.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.27412701.efficacy-and-safety-of-liraglutide-a-once-daily.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.27658921.initiation-and-intensification-strategies-in-type.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.27696221.a-review-of-insulin-degludec-insulin-aspart.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.27783551.a-systematic-review-of-insulin-adherence-measures.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.27853981.intensification-of-idegasp-twice-daily-adding.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.28185141.pharmacokinetic-properties-of-fast-acting-insulin.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33963681.liraglutide-pharmacokinetics-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34077951.a-factor-viiia-mimetic-bispecific-antibody-mim8.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34101651.current-state-of-antigen-specific-immunotherapy.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34140791.risk-of-thyroid-cancer-associated-with-use-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34152221.diversification-of-the-crispr-toolbox.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34315481.capture-a-multinational-cross-sectional-study.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.36738891.post-hoc-analysis-of-sustain-6-and-pioneer-6.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.37118061.nedosiran-in-primary-hyperoxaluria-subtype-3.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.37196421.reducing-bmi-below-the-obesity-threshold-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.38707801.nedosiran-safety-and-efficacy-in-ph1-interim.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40482671.once-weekly-icosema-versus-once-weekly-insulin.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40601241.population-pharmacokinetic-and-pharmacodynamic.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40730031.effects-of-semaglutide-with-or-without.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.9802741.improved-glycemic-control-with-insulin-aspart-a.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.10640512.pharmacokinetics-of-the-rapid-acting-insulin.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.11213882.comparison-of-the-soluble-basal-insulin-analog.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.12882862.a-comparison-of-postprandial-and-preprandial.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.27709762.pharmacological-properties-of-faster-acting.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.27739002.switching-from-biphasic-human-insulin-to-premix.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.27873152.a-comparison-of-pharmacokinetic-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.28008782.understanding-bolus-insulin-dose-timing-the.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.28345792.adding-fast-acting-insulin-aspart-to-basal.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.28371032.insight-into-health-related-quality-of-life-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.28386912.neurologypsychiatric-safety-with-liraglutide-3-0.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.28523482.an-rct-investigating-patient-driven-versus.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.28918652.investigation-of-pump-compatibility-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.28950422.liraglutide-and-cardiovascular-outcomes-in-adults.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29498782.factors-associated-with-pain-severity-pain.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29671202.pharmacokinetics-and-pharmacodynamics-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33571362.long-term-safety-of-growth-hormone-treatment-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33594582.outcomes-in-glp-1-ra-experienced-patients.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33606902.applying-rewind-cardiovascular-disease-criteria.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33782832.effect-of-oral-semaglutide-on-the.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33944562.molecular-engineering-of-insulin-icodec-the.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34015342.il-6-inhibition-with-ziltivekimab-in-patients-at.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.37055712.the-improved-health-utility-of-once-weekly.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.37156252.switching-to-once-weekly-insulin-icodec-versus.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.37354562.once-weekly-insulin-icodec-vs-once-daily-insulin.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40316472.action-teens-perceptions-and-attitudes-towards.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40400262.efficacy-safety-and-insulin-like-growth-factor.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40459962.perceptions-of-high-sensitivity-c-reactive.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40464112.estimating-the-association-and-timing-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40467432.perception-of-obesity-and-weight-loss-attitudes.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40490062.model-informed-drug-development-of-mim8-a.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40676962.the-epidemiology-clinical-characteristics-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.25036533.liraglutide-s-safety-tolerability.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.25212693.the-effect-of-liraglutide-on-endothelial-function.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.25974283.weight-sparing-effect-of-insulin-detemir-a.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.26225223.the-effects-of-a-glp-1-analog-on-glucose.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.26681713.efficacy-and-safety-of-liraglutide-versus-placebo.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.26849483.perceptions-of-diabetes-control-among-physicians.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.27186543.efficacy-and-safety-of-biphasic-insulin-aspart.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.27198973.improvements-in-health-related-quality-of-life.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.28138803.effectiveness-and-persistence-of-liraglutide.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.28442823.insulin-degludec-200-units-ml-is-associated-with.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.28595133.nonclinical-pharmacokinetic-and-pharmacodynamic.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32647053.effects-of-liraglutide-on-cardiovascular-outcomes.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32815423.clinical-review-of-the-efficacy-and-safety-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32815453.integrating-oral-semaglutide-into-clinical.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32874673.real-world-persistence-with-liraglutide-3-0-mg.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32896073.liraglutide-treatment-improves-endothelial.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32996693.development-of-a-hypoglycaemia-risk-score-to.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33132503.how-effective-is-the-fixed-ratio-combination-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33439583.cardiovascular-outcomes-safety-and-tolerability.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33522653.identified-unmet-needs-and-proposed-solutions-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.35434913.comparison-of-the-injection-site-experience-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.35521713.dose-exposure-igf-i-response-of-once-weekly.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.35602193.insulin-at-100-still-central-in-protein-based.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.35680133.in-vitro-cyp450-enzyme-down-regulation-by.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.36514273.investigating-the-potential-non-authorized-use-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.36696203.the-effect-of-a-next-generation-factor-viii.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.36869853.once-weekly-semaglutide-use-in-patients-with-type.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.38663943.the-human-insulin-thermal-solution-project-a.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.38734133.the-ethink-study-cognitive-and-behavioral.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.38740993.long-term-weight-loss-effects-of-semaglutide-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.38907683.effect-of-semaglutide-on-regression-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39217553.effects-of-semaglutide-on-heart-160-failure.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39228093.therapeutic-inertia-in-obesity-management-among.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39339743.disparities-in-the-cardiometabolic-impact-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39344833.efficacy-and-safety-of-once-weekly-insulin-icodec.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39425483.icodec-a-novel-once-weekly-basal-insulin-for.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39631663.pharmacokinetic-pharmacodynamic-modeling-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.21270174.insulin-degludec-in-type-1-diabetes-a-randomized.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.21555744.enhanced-pharmacokinetic-properties-of-a.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.21792324.insulin-initiation-and-intensification-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.22590494.molecular-characterisation-of-long-acting-insulin.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.23130654.hypoglycaemia-risk-with-insulin-degludec-compared.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.23340894.the-efficacy-and-safety-of-insulin-degludec-given.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.23670204.safety-and-effectiveness-of-insulin-detemir-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.24163264.insulin-degludec-pharmacokinetics-in-patients.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.24228724.prevalence-of-diabetes-complications-in-people.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.24246344.reduced-risk-of-hypoglycemia-with-insulin.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.24329524.effect-of-once-daily-insulin-detemir-on-oral.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31496854.mild-severe-hemophilia-b-impacts-relationships-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31897524.effects-of-once-weekly-semaglutide-vs-once-daily.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31903724.a-greater-proportion-of-participants-with-type-2.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32053994.tissue-distribution-and-receptor-activation-by.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32372454.the-effect-of-glucagon-like-peptide-1-receptor.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32603494.similar-safety-and-efficacy-in-previously-treated.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.35332654.cardiovascular-efficacy-of-liraglutide-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.35386274.switching-to-nonacog-beta-pegol-in-hemophilia-b.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.35724304.changes-in-glucose-metabolism-and-glycemic-status.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.36531884.hemoglobin-a1c-reduction-with-the-glp-1-receptor.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.36801984.effects-of-semaglutide-on-albuminuria-and-kidney.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.38907684.semaglutide-and-cardiovascular-outcomes-by.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.38913004.semaglutide-and-nyha-functional-class-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.12941725.continuous-subcutaneous-insulin-infusion-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.15111525.insulin-detemir-offers-improved-glycemic-control.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.15161785.improved-glycemic-control-with-no-weight-increase.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.17647145.proportional-dose-response-relationship-and-lower.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.17975905.structure-activity-and-protraction-relationship.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.18644065.antibody-response-to-insulin-in-children-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.18931095.efficacy-and-safety-comparison-of-liraglutide.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.20380655.improved-glycaemic-control-with-minimal.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.20590735.patient-reported-outcomes-following-treatment.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.20636965.similarity-of-pharmacodynamic-effects-of-a-single.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.20713345.a-comparison-of-twice-daily-biphasic-insulin.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.22818015.ten-years-of-experience-with-biphasic-insulin.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.28656605.somapacitan-a-once-weekly-reversible.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.28854085.liraglutide-and-renal-outcomes-in-type-2-diabetes.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.28913575.day-to-day-fasting-glycaemic-variability-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29053215.identification-of-barriers-to-insulin-therapy-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29328905.diagnosis-and-care-of-patients-with-mild.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29340855.the-relationship-between-target-joints-and-direct.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29448295.recombinant-fxiii-rfxiii-a2-prophylaxis.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32369845.long-term-safety-and-efficacy-of-nonacog-beta.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32618405.practical-use-of-insulin-degludec-insulin-aspart.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32666165.switching-to-degludec-is-associated-with-reduced.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32747385.incidence-and-costs-of-cardiovascular-events-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32827435.efficacy-of-once-weekly-semaglutide-vs.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32935465.development-of-the-impact-of-weight-on-daily.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32940955.long-term-safety-and-efficacy-of-n8-gp-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33006125.clinical-characteristics-of-a-non-alcoholic-fatty.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33088015.the-long-term-safety-and-effectiveness-of-growth.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33280425.risk-factors-for-kidney-disorders-in-patients.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33522655.current-challenges-for-men-and-women-with.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33567185.once-weekly-semaglutide-in-adults-with-overweight.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.36380045.weekly-somapacitan-had-no-adverse-effects-on.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.36905345.effect-of-once-weekly-subcutaneous-semaglutide.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.36905485.correlation-between-time-in-range-and-hba1c-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.37294245.design-and-baseline-characteristics-of-step-hfpef.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.37424165.a-model-based-approach-to-predict-individual.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39991735.efficacy-in-japanese-adults-with-growth-hormone.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40063715.effect-of-oral-semaglutide-versus-comparators-on.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40169145.semaglutide-and-walking-capacity-in-people-with.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40186685.the-effect-of-once-weekly-insulin-icodec-vs.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40215125.cardiovascular-events-mortality-and-incident.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40577405.treatment-and-disease-burden-in-a-cohort-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40691365.modulation-of-metabolic-inflammatory-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.22830956.the-safety-and-efficacy-of-adding-once-daily.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.23043166.insulin-degludec-versus-insulin-glargine-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.23586846.meta-analysis-of-insulin-aspart-versus-regular.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.23952326.comparison-of-insulin-degludec-with-insulin.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.24467746.glp-1-receptor-localization-in-monkey-and-human.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.24843416.28-week-randomized-multicenter-open-label.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.25641556.safety-and-pharmacokinetics-of-anti-tfpi-antibody.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.26351466.noonan-syndrome-and-turner-syndrome-patients.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.26450456.similar-risk-of-exercise-related-hypoglycaemia.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.26727076.reversible-albumin-binding-gh-possesses-a.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.26743666.clinical-inertia-with-regard-to-intensifying.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30891886.lower-rates-of-hypoglycaemia-in-older-individuals.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30903796.effect-of-additional-oral-semaglutide-vs.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30949906.efficacy-and-safety-of-fast-acting-insulin-aspart.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30974986.efficacy-and-safety-of-degludec-compared-to.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31530666.oral-semaglutide-versus-empagliflozin-in-patients.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31667706.glomerular-filtration-rate-and-associated-risks.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31769496.efficacy-and-safety-of-semaglutide-for-type-2.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31887776.body-mass-index-best-predicts-recovery-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31972476.growth-hormone-replacement-in-adults-real-world.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30429357.transcellular-stomach-absorption-of-a-derivatized.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30456887.comparison-of-the-hat-study-the-largest-global.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30524377.shared-decision-making-in-growth-hormone.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30603257.insulin-degludec-versus-insulin-glargine-both.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30653847.liraglutide-effects-in-a-paediatric-7-11-y.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30828917.trial-design-and-baseline-data-for-lira-prime-a.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31215727.improved-treatment-satisfaction-in-patients-with.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31530667.efficacy-safety-and-tolerability-of-oral.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31705547.insulin-degludec-liraglutide-ideglira-maintains.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31782067.the-effect-of-fluctuating-temperature-on-the.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31903697.the-relationship-between-hba1c-and-hypoglycaemia.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32090517.liraglutide-3-0-mg-and-intensive-behavioral.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34322967.effect-of-insulin-degludec-versus-insulin.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34605127.impact-of-kidney-function-on-the-safety-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34622567.maintenance-of-glycaemic-control-with-liraglutide.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34741327.editorial-evolution-of-glp-1-receptor-agonists.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34939937.cardiovascular-safety-of-growth-hormone-treatment.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.35015037.effect-of-weekly-subcutaneous-semaglutide-vs.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.37417197.pharmacokinetics-and-pharmacodynamics-of-an-oral.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.37554127.achieving-consensus-on-the-language-of-obesity-a.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39279647.impact-of-baseline-characteristics-on-the.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39348567.advances-in-insulin-a-review-of-icodec-as-a.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39366717.recent-trends-in-glp-1-ra-and-sglt2i-use-among.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39412407.icodec-onwards-a-review-of-the-first-once-weekly.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40016997.the-pleiotropic-effects-of-glucagon-like.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40098267.efficacy-and-hypoglycaemia-outcomes-with.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.25380238.expression-and-distribution-of-glucagon-like.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.25419888.management-of-type-2-diabetes-mellitus-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.25504028.is-there-a-link-between-liraglutide-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.25563978.investigation-of-the-physico-chemical-properties.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.25656058.leader-2-baseline-calcitonin-in-9340-people-with.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.26249018.delay-in-treatment-intensification-increases-the.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.26358288.a-phase-2-randomized-dose-finding-study-of-the.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.26565758.understanding-adherence-to-medications-in-type-2.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.26782928.pharmacokinetic-and-prandial-pharmacodynamic.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.26855018.leader-4-blood-pressure-control-in-patients-with.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.26990378.effect-of-adding-insulin-degludec-to-treatment-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31032548.gaps-to-bridge-misalignment-between-perception.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31144428.use-of-fast-acting-insulin-aspart-in-insulin-pump.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31188288.an-individualized-approach-to-the-management-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31246368.effect-of-semaglutide-on-liver-enzymes-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31282028.long-term-efficacy-and-safety-of-combined-insulin.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31294338.fixed-doses-of-n8-gp-prophylaxis-maintain.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31354248.real-world-utilities-and-health-related.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31385938.role-of-ultrafast-acting-insulin-analogues-in-the.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33892998.reducing-kidney-function-decline-in-patients-with.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33894838.safety-tolerability-pharmacokinetics-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34009708.potential-kidney-protection-with-liraglutide-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34132018.efficacy-of-liraglutide-added-to-sodium-glucose.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34964458.effective-gh-replacement-with-once-weekly.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.35019238.safety-pharmacokinetics-and-pharmacodynamics-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.35245328.preclinical-evaluation-of-a-protracted.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.35279938.regulation-of-coagulation-by-tissue-factor.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.35466848.pharmacological-profile-of-once-weekly-injectable.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.36322838.once-weekly-semaglutide-in-adolescents-with.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39271158.somapacitan-in-children-born-sga-52-week.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39368488.improved-treatment-satisfaction-with-once-weekly.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39424598.design-and-baseline-characteristics-of-the-stride.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39472768.prx004-in-variant-amyloid-transthyretin-attrv.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39521008.concizumab-prophylaxis-in-people-with-haemophilia.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.21844879.safety-tolerability-and-sustained-weight-loss.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.22882249.insulin-aspart-has-a-shorter-duration-of-action.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.23451759.a-comparison-of-health-related-quality-of-life.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.23683069.liraglutide-suppresses-postprandial-triglyceride.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.23942319.tolerability-of-nausea-and-vomiting-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.24041349.benchmarks-for-interpretation-of-score.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.24263619.ultra-long-pharmacokinetic-properties-of-insulin.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.24477669.safety-tolerability-and-efficacy-of-insulin.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.25261199.recombinant-long-acting-glycopegylated-factor-ix.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.25581159.steady-state-is-reached-within-2-3-days-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.25603819.comparable-liraglutide-pharmacokinetics-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.26132939.a-randomized-controlled-trial-of-3-0-mg-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31721979.occurence-of-first-and-recurrent-major-adverse.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31816159.safety-and-efficacy-of-turoctocog-alfa-in-the.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32017339.awareness-care-and-treatment-in-obesity.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32306819.a-survey-of-physician-experience-and-treatment.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32815439.oral-semaglutide-in-patients-with-type-2-diabetes.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32910489.glycaemic-and-non-glycaemic-efficacy-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33184979.effects-of-oral-semaglutide-on-energy-intake.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33627989.optimizing-therapeutic-outcomes-with-oral.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33723769.once-daily-oral-semaglutide-versus-injectable.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33807699.the-role-of-the-transsulfuration-pathway-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33912759.hepatic-lactate-dehydrogenase-a-an-rna.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34060209.insights-into-the-early-use-of-oral-semaglutide.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.37148899.switching-to-once-weekly-insulin-icodec-versus.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.37171239.nonalcoholic-steatohepatitis-diagnosis-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.37385279.efficacy-and-safety-of-once-daily-oral.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.37597919.a-survey-of-obesity-education-and-training-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.37690519.results-from-three-phase-1-trials-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39778759.type-2-diabetes-disease-and-management-patterns.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39780249.evoke-and-evoke-design-of-two-large-scale.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39811679.utilities-associated-with-the-treatment-of-growth.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39832779.determinants-of-adherence-to-obesity-medication.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40768189.semaglutide-2-4-160-mg-clinical-outcomes-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40875179.hypoglycemia-related-hospitalization-in-adults.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40937499.a-review-of-multidisciplinary-care-in-metabolic.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40956259.frailty-and-effects-of-semaglutide-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.NN196875113a9.phase-3-trial-of-semaglutide-in-metabolic.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.NN195fb5bdbcb.association-of-index-and-changes-in-fibrosis-4.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.NN19999ad8a83.efficacy-and-safety-of-monlunabant-in-adults-with.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.NN1977da9b921.coadministered-cagrilintide-and-semaglutide-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.NN19787a75d35.cagrilintide-semaglutide-in-adults-with.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.NN197e3dd0b9f.sat-694-long-term-effectiveness-and-safety-of-gh.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.NN1982dadbe17.modulation-of-metabolic-inflammatory-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.23551900.a-comparison-of-insulin-detemir-and-neutral.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.24277680.insulin-degludec-pharmacokinetic-properties-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.24443830.a-comparison-of-adding-liraglutide-versus-a.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.24608440.the-human-glp-1-analogs-liraglutide-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.24702700.efficacy-and-safety-of-insulin-degludec-given-as.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.25081590.insulin-degludec-versus-insulin-glargine-in-type.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.25202980.the-arcuate-nucleus-mediates-glp-1-receptor.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.25846340.faster-acting-insulin-aspart-earlier-onset-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.25855340.counter-regulatory-hormone-responses-to.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.25980900.one-year-efficacy-and-safety-of-a-fixed.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.26086190.comparison-of-the-pharmacokinetic-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.26284720.efficacy-of-liraglutide-for-weight-loss-among.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31186120.oral-semaglutide-versus-subcutaneous-liraglutide.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31186300.pioneer-1-randomized-clinical-trial-of-the.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31187420.clinical-use-of-degludec-in-children-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31413650.efficacy-of-ehl-n9-gp-for-on-demand-treatment-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31502110.family-members-the-forgotten-players-in-the.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31549480.enhanced-potency-of-recombinant-factor-viia-with.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.35191180.a-novel-next-generation-fviiia-mimetic-mim8-has.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.35441470.weight-regain-and-cardiometabolic-effects-after.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.37694740.pharmacokinetic-and-pharmacodynamic-properties-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.37822270.proportion-of-participants-with-type-2-diabetes.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.37952180.effects-of-semaglutide-on-symptoms-function-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.38092710.weight-loss-and-treatment-patterns-in-a.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39820580.once-weekly-icosema-versus-once-weekly.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40008550.estimating-healthcare-resource-utilisation-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40016570.once-weekly-insulin-icodec-versus-once-daily.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40067340.noninvasive-identification-of-metabolic.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40104140.systemic-inflammation-prevalence-in-patients-with.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40261420.smart-stone-multidisciplinary-team-mdt-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40802020.clinical-use-of-once-weekly-insulin-icodec.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40825340.once-weekly-semaglutide-2-183-4-mg-in-an-asian.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.4518180.efficacy-and-safety-of-insulin-degludec-200-u-ml.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.11679431.systemic-administration-of-the-long-acting-glp-1.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.28233381.pharmacokinetics-of-a-novel-extended-half-life.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.28476871.amylase-lipase-and-acute-pancreatitis-in-people.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.28780521.early-growth-hormone-treatment-start-in-childhood.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.28984041.safety-and-efficacy-of-the-combination-of-the.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29369801.prediction-of-human-pharmacokinetics-of-activated.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29667921.glycemic-control-of-type-2-diabetes-mellitus.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29678811.clinical-inertia-in-type-2-diabetes-management.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29713961.a-systematic-literature-review-and-network.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29862621.achieving-glycaemic-control-without-weight-gain.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29884191.prevalence-of-cardiovascular-disease-in-type-2.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29979821.advantages-disadvantages-and-optimization-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30411401.inhibitors-in-haemophilia-a-and-b-management-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34387411.dual-ii-china-superior-hba1c-reductions-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34601071.absorption-metabolism-and-excretion-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34728221.basal-weekly-insulins-the-way-of-the-future.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34764641.illustrative-cases-from-the-pathfinder-clinical.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.37231911.disease-burden-and-health-status-among-people.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.37308751.hypoglycaemia-frequency-and-physiological.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.37328931.improved-health-related-quality-of-life-with.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.37364771.in-vitro-interaction-of-tetrahydrouridine-with.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.37406251.effective-gh-replacement-with-somapacitan-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.38722461.the-effect-of-various-degrees-of-renal-or-hepatic.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.38880091.perspectives-in-managing-kidney-disease-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.14571692.pharmacokinetic-and-pharmacodynamic-properties-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.15209772.hypoglycaemia-with-insulin-aspart-a.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.15616022.glucagon-like-peptide-1-can-directly-protect-the.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.16918592.time-action-profile-of-insulin-detemir-and-nph.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.17277042.using-continuous-glucose-monitoring-to-measure.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.18201212.liraglutide-a-once-daily-human-glp-1-analogue.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.18290862.does-serum-1-5-anhydroglucitol-establish-a.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.19183322.beneficial-effects-of-once-daily-liraglutide-a.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.19317822.liraglutide-a-once-daily-human-glp-1-analogue.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.20602172.patient-treatment-satisfaction-after-switching-to.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.21309842.liraglutide-improves-treatment-satisfaction-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.21388442.patient-reported-outcomes-are-superior-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29688502.semaglutide-added-to-basal-insulin-in-type-2.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29720192.the-impact-of-severe-haemophilia-and-the-presence.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29898902.neoplasms-reported-with-liraglutide-or-placebo-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30004622.haemophilia-clinical-care-and-research-needs.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30014302.a-26-week-randomized-trial-of-insulin-detemir.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30179272.reliability-and-validity-of-patient-reported.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30457692.ranges-and-drivers-of-risk-associated-with-sports.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30510462.phenotypical-variability-in-congenital-fvii.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30666772.the-rate-of-hyperglycemia-and-ketosis-with.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30705032.gene-based-fviia-prophylaxis-modulates-the.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34338402.semaglutide-single-dose-pen-injector-post-hoc.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34514682.gastrointestinal-tolerability-of-once-weekly.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34562332.post-hoc-analysis-on-the-long-term-response-to.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34637072.arise-a-prospective-non-interventional.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34637112.glycaemic-control-in-people-with-diabetes.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34757052.management-of-cardiac-aspects-in-children-with.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.37867532.decision-making-in-clinical-trials-interim.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.37985992.once-weekly-glucagon-like-peptide-1-receptor.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.38379002.pharmacokinetic-and-pharmacodynamic-properties-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.38623572.cardiovascular-disease-in-patients-with-metabolic.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.38951942.once-weekly-insulin-icodec-compared-with-daily.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40833702.quantifying-patient-preferences-for-basal-insulin.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40934962.comparative-effectiveness-of-ow-glp-1-ras-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40985232.exploration-of-multiple-non-invasive-tests-for.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.7589842.action-profile-of-cobalt-iii-insulin-a-novel.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.8554512.albumin-binding-of-insulins-acylated-with-fatty.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.10834413.use-of-insulin-aspart-a-fast-acting-insulin.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.10866053.correlations-of-receptor-binding-and-metabolic.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.11872653.mode-of-transcapillary-transport-of-insulin-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.28605603.efficacy-and-safety-of-degludec-versus-glargine.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.28681633.major-and-minor-classifications-for-surgery-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.28704103.postprandial-dosing-of-bolus-insulin-in-patients.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.28913543.devote-3-temporal-relationships-between-severe.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29109363.efficacy-and-safety-of-two-doses-of-norditropin.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29498783.patient-reported-outcomes-and-joint-status-across.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29618923.patient-preferences-in-the-treatment-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29623593.efficacy-and-safety-of-rapid-acting-insulin.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29707863.glucagon-like-peptide-1-receptor-expression-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33536803.recombinant-fviii-products-turoctocog-alfa-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33727283.am833-is-a-novel-agonist-of-calcitonin-family-g.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33841883.body-mass-index-and-risk-of-obesity-related.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33988293.concomitant-use-of-bypassing-agents-with.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34009833.cardiovascular-disease-in-patients-with-type-2.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34080123.effect-of-various-dosing-conditions-on-the.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34135013.association-between-glucagon-like-peptide-1.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34288673.development-of-cagrilintide-a-long-acting-amylin.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34324263.non-alcoholic-fatty-liver-disease-related-risk-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34481803.safety-pharmacodynamics-and-exposure-response.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34626473.letter-to-the-editor-from-s-vendahl-et-al.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34757053.european-medical-education-initiative-on-noonan.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.37208593.clinical-characteristics-and-management-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.37786283.personalized-prediction-of-change-in-fasting.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.37818403.model-based-analysis-of-igf-i-response-dosing.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.37824563.a-next-generation-fviii-mimetic-bispecific.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.37874463.recognition-and-practice-of-hypopituitarism-after.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.38913003.efficacy-of-semaglutide-by-sex-in-obesity-related.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.38955363.effect-of-semaglutide-on-kidney-function-across.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39717993.determinants-of-liraglutide-treatment.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39752213.a-european-survey-to-identify-challenges-in-the.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40106223.the-prevalence-of-atherosclerotic-cardiovascular.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40156843.oral-semaglutide-and-cardiovascular-outcomes-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40345413.effect-of-once-weekly-subcutaneous-semaglutide-on.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.24713674.comment-on-andersen-et-al.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.24958464.barriers-to-initiating-insulin-in-type-2-diabetes.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.26816604.liraglutide-is-effective-and-well-tolerated-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.26833744.exposure-response-analyses-of-liraglutide-3-0-mg.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.26864124.leader-5-prevalence-and-cardiometabolic-impact.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.28295934.insulin-degludec-lower-day-to-day-and-within-day.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.28761654.treatment-patterns-and-clinical-characteristics.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.28941314.semaglutide-improves-postprandial-glucose-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29283504.association-of-postprandial-and-fasting-plasma.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29498784.assessments-of-pain-functional-impairment.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29766634.semaglutide-induces-weight-loss-in-subjects-with.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29797004.assessing-the-impact-of-growth-hormone-deficiency.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32643514.practical-guidance-for-use-of-oral-semaglutide-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32815454.glp-1-receptor-agonists-in-the-treatment-of-type.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32960514.once-weekly-insulin-for-type-2-diabetes-without.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33185364.a-placebo-controlled-trial-of-subcutaneous.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33341524.adult-growth-hormone-deficiency-optimizing.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33522654.impact-of-haemophilia-on-patients-with.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.36876594.impact-of-bmi-and-comorbidities-on-efficacy-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.36945734.effects-of-oral-semaglutide-on-cardiovascular.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.36979894.unlocking-the-pragmatic-potential-of-regenerative.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.37067624.healthcare-utilization-quality-of-life-and-work.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.37191234.glucagon-like-peptide-1-receptor-agonists-to.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.37283064.weight-change-and-risk-of-obesity-related.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.38914124.effects-of-semaglutide-with-and-without.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39118004.diagnostic-and-therapeutic-challenges-for-pcps.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39161804.the-concizumab-pen-injector-is-easy-to-use-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39217564.inflammation-in-obesity-related-hfpef-the.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.23186975.liraglutide-achieves-a1c-targets-more-often-than.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.23371395.observational-study-of-once-daily-insulin-detemir.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.23393185.efficacy-and-safety-of-insulin-degludec-in-a.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.23551925.the-once-daily-human-glp-1-analogue-liraglutide.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.23670205.safety-and-effectiveness-of-insulin-aspart-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.23749405.a-comparison-of-the-steady-state-pharmacokinetic.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.23812875.insulin-degludec-once-daily-in-type-2-diabetes.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.24112375.weight-change-upon-once-daily-initiation-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.24170235.elderly-patients-with-diabetes-experience-a-lower.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.24199745.a-prospective-claims-based-assessment-of-the.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.24446385.modeling-of-24-hour-glucose-and-insulin-profiles.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.24467565.insulin-degludec-s-ultra-long-pharmacokinetic.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29483185.efficacy-and-safety-of-ideglira-versus.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29498785.what-can-we-learn-from-using-formal.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29693715.pharmacokinetics-safety-and-tolerability-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29804265.lessons-from-a-systematic-literature-review-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29912995.an-overview-of-the-burden-of-illness-and-the-role.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29944195.recommendations-on-multidisciplinary-management.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30004625.recombinant-activated-factor-vii-in-approved.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30122305.efficacy-and-safety-of-semaglutide-compared-with.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.30383495.efficacy-and-safety-of-ideglira-in-older-patients.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33727615.hyperinsulinaemic-hypoglycaemia-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33754315.effect-of-kidney-or-hepatic-impairment-on-the.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33819375.thrombin-generation-potential-in-the-presence-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33875485.switching-to-once-weekly-insulin-icodec-versus.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34187185.effect-of-liraglutide-on-arterial-inflammation.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34189795.a-selective-role-for-receptor-activity-modifying.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.38058795.fibroscan-aspartate-aminotransferase-fast-score.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.38065435.evaluation-of-long-acting-glp1r-gcgr-agonist-in-a.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.38240875.real-world-use-of-oral-semaglutide-in-adults-with.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40819425.prevalence-treatment-patterns-burden-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40953015.analysis-of-patients-preferences-in-type-2.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40980545.comparative-outcomes-of-gh-treatment-in-pediatric.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.41051695.pharmacokinetic-characteristics-of-a-once-weekly.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.10826516.pharmacokinetic-and-pharmacodynamic-properties-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.10872536.post-prandial-administration-of-the-insulin.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.12401756.a-direct-comparison-of-insulin-aspart-and-insulin.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.26773446.safety-and-efficacy-of-insulin-degludec-insulin.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.26936426.efficacy-and-safety-of-liraglutide-a-once-daily.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.26970716.nonacog-beta-pegol-n9-gp-in-haemophilia-b-a.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.27593206.impact-of-the-mode-of-protraction-of-basal.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.27633186.semaglutide-and-cardiovascular-outcomes-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.27878566.pharmacokinetic-and-pharmacodynamic-properties-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.28150516.efficacy-and-safety-of-fixed-ratio-combination-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.28349386.pharmacokinetics-and-tolerability-of-a-single.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.28483786.faster-aspart-versus-insulin-aspart-as-part-of-a.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.31984646.liraglutide-as-add-on-to-sodium-glucose.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32250536.risk-of-severe-hypoglycaemia-and-its-impact-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34182866.characteristics-of-pregnant-women-with-diabetes.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34330786.risk-of-major-congenital-malformations-or.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34381196.gdf15-emerging-biology-and-therapeutic.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34400466.100-years-on-the-impact-of-the-discovery-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.37046366.neutrophil-to-lymphocyte-ratio-predicts.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.37164146.contemporary-use-of-cardiovascular-risk-reduction.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.37211246.efficacy-and-safety-of-interleukin-6-inhibition.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.37334526.real-world-study-of-ethnic-differences-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.37356066.weekly-icodec-versus-daily-glargine-u100-in-type.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39261416.efficacy-and-safety-of-somapacitan-relative-to.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39262646.thromboembolic-events-in-severe-postpartum.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39708086.a-bioequivalence-study-of-two-formulations-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39823186.comparing-demographic-clinical-characteristics.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39824696.clinical-characteristics-affecting-weight-loss-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39930546.efficacy-and-hypoglycaemia-outcomes-with.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40040516.continuous-glucose-monitoring-based-titration-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.15516157.insulin-detemir-a-review-of-its-use-in-the.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.16398567.premixed-insulin-analogues-for-the-treatment-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.16732007.a-26-week-randomized-parallel-treat-to-target.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.18275357.evaluation-of-treatment-satisfaction-associated.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.18463047.role-of-insulin-signaling-in-maintaining-energy.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.19049377.the-pharmacokinetic-and-pharmacodynamic.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.19289857.efficacy-and-safety-of-the-human-glucagon-like.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.19925617.adding-liraglutide-to-oral-antidiabetic-drug.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.20133507.population-pharmacokinetics-of-liraglutide-a.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.20199137.efficacy-and-safety-of-the-once-daily-human-glp-1.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.20429817.starting-insulin-therapy-with-basal-insulin.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.20449697.glycemic-control-and-long-acting-insulin-analog.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.25683037.insulin-degludec-in-combination-with-bolus.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.26407587.the-impact-of-nocturnal-hypoglycemia-on-sleep-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.26484727.a-meta-analysis-of-rate-ratios-for-nocturnal.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.26773557.insulin-degludec-insulin-aspart-once-daily-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.26936227.recombinant-long-acting-glycopegylated-factor-ix.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.27174727.nonacog-beta-pegol-in-previously-treated-children.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.27186357.long-acting-glucagon-like-peptide-1-receptor.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.27295427.liraglutide-and-cardiovascular-outcomes-in-type-2.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.27480487.low-factor-consumption-for-major-surgery-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32193837.once-weekly-semaglutide-reduces-hba1c-and-body.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32206477.the-development-of-oral-semaglutide-an-oral.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32209647.a-randomized-trial-evaluating-the-efficacy-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32306477.the-association-between-anti-insulin-aspart.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32383257.effects-of-a-selective-long-acting-amylin.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32544297.long-term-safety-and-efficacy-of-n8-gp-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32643857.impact-of-microvascular-disease-on-cardiovascular.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32897147.introducing-a-novel-therapy-for-type-2-diabetes.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32910487.safety-and-tolerability-of-once-weekly-glp-1.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33058727.total-synthesis-of-semaglutide-based-on-a-soluble.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33199417.impact-of-patient-characteristics-on-efficacy-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33464677.nonalcoholic-fatty-liver-disease-as-a-metabolic.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.35131037.semaglutide-once-a-week-in-adults-with-overweight.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.35257457.changes-over-time-in-the-cardiovascular-risk.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.36007597.phyox2-a-pivotal-randomized-study-of-nedosiran.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.36200477.semaglutide-improves-cardiometabolic-risk-factors.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.36449307.association-of-interleukin-6-inhibition-with.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.37992687.use-of-a-biomimetic-hydrogel-depot-technology-for.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.38028337.case-study-of-semaglutide-and-cardiovascular.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.38050097.evaluating-drug-drug-interaction-risk-associated.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.38438707.insulin-degludec-in-people-with-type-2-diabetes.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.38861137.real-world-use-of-oral-semaglutide-in-adults-with.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.12502678.comparison-of-an-insulin-analog-insulin-aspart.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.15298338.insulin-analogues-insulin-detemir-and-insulin.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.15975098.comparison-of-three-multiple-injection-regimens.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.16489968.biphasic-insulin-aspart-vs-human-insulin-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.17989308.a-randomized-trial-comparing-continuous.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.18215338.biphasic-insulin-aspart-30-treatment-in-patients.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.18269638.improved-glycaemic-control-of-thrice-daily.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.18387078.long-term-efficacy-and-safety-of-insulin-detemir.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.18811598.the-improve-study-a-multinational-observational.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.19688338.liraglutide-vs-insulin-glargine-and-placebo-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.21134878.comparison-of-pharmacokinetic-properties.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.21205128.liraglutide-a-once-daily-human-glucagon-like.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29129018.a-32-week-randomized-comparison-of-stepwise.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29188338.effects-of-hypoglycaemia-on-working-memory-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29277968.efficacy-and-safety-of-adding-liraglutide-to.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29493118.greater-early-postprandial-suppression-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29536338.a-randomized-trial-investigating-the.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29578308.moderate-and-severe-haemophilia-in-spain-an.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29652668.still-too-little-too-late-ten-years-of-growth.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29713208.educational-needs-of-hematologists-and-laboratory.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29729048.regional-variations-in-definitions-and-rates-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29760228.effect-of-liraglutide-on-cardiovascular-events-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29893488.effect-of-once-weekly-semaglutide-on-the.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32366578.cardiovascular-risk-reduction-with-liraglutide.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32744418.effects-of-glucagon-like-peptide-1-receptor.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32910488.managing-the-multifaceted-nature-of-type-2.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.32924568.impact-of-fast-acting-insulin-aspart-on-glycemic.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33104418.facilitating-the-adherence-journey-of-children.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33159658.pharmacokinetics-safety-and-tolerability-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33313798.optimal-monitoring-of-weekly-igf-i-levels-during.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33318068.long-term-efficacy-and-safety-of-oral-semaglutide.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.33440388.long-term-effectiveness-and-safety-of-childhood.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34462588.oral-delivery-of-systemic-monoclonal-antibodies.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.34472698.efficacy-and-safety-of-oral-semaglutide-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.38330988.efficacy-and-safety-of-once-weekly-semaglutide.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.38442988.greater-persistence-and-adherence-to-basal.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.38711208.pioneer-real-japan-baseline-characteristics-of-a.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.40758358.oral-semaglutide-in-an-east-asian-population-with.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.10525669.mechanism-of-protracted-metabolic-effects-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.10923219.rapid-appearance-and-onset-of-action-of-insulin.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.28404659.early-glycemic-control-and-magnitude-of-hba1c.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.28826659.haemophilia-b-where-are-we-now-and-what-does-the.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29045079.improvements-in-health-related-quality-of-life.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29106039.a-european-multicentre-retrospective.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29178519.semaglutide-reduction-in-glycated-haemoglobin.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29218759.impact-of-pain-and-functional-impairment-in-us.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29468559.15-years-of-experience-with-biphasic-insulin.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29582559.preclinical-pharmacokinetics-and-biodistribution.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29623579.pharmacokinetics-safety-and-tolerability-of-oral.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29741299.methodologies-for-data-collection-in-congenital.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.29897249.a-randomized-study-investigating-the-effect-of.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.35308099.turoctocog-alfa-pegol-n8-gp-in-severe.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.36254579.semaglutide-for-the-treatment-of-overweight-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.36255609.psychometric-validation-of-the-growth-hormone.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.36467859.effects-of-once-weekly-semaglutide-2-4-mg-on.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.36502289.semaglutide-for-cardiovascular-event-reduction-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.36524539.prevalence-of-baseline-cardiac-arrhythmias-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39217559.the-effect-of-semaglutide-on-mortality-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.39279639.cagrilintide-is-not-associated-with-clinically.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.NN190a3857a3e.tolerability-pharmacokinetics-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.NN190a3857e27.oral-mrna-delivery-using-capsule-mediated.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.NN190a3858581.glucagon-like-peptide-1-receptor-agonists-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.NN190a3858f11.burden-of-illness-in-people-with-alzheimer-s.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.NN190a38593fa.cases-of-less-than-expected-fviii-activity-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.NN196af39fe96.safety-considerations-of-semaglutide-in-the.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.NN19265ec8b86.comparing-machine-learning-and-advanced-methods.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.NN192de75285e.once-weekly-semaglutide-in-persons-with-obesity.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.NN1994c56cd03.once-weekly-semaglutide-7-2-mg-in-adults-with.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.NN1994c6ae0d2.once-weekly-semaglutide-7-2-mg-in-adults-with.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.NN19a0258a0d2.semaglutide-and-cardiovascular-outcomes-by.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.NN19a58b3e511.semaglutide-and-cardiovascular-outcomes-by.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.NN19a5eaa6479.the-identification-of-potential-treatment-targets.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.38785209.effects-of-semaglutide-on-chronic-kidney-disease.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.41184092.exploring-the-relationship-between-obesity.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.41045908.semaglutide-and-exercise-function-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.NN19a5ec81bd3.coramitug-a-humanized-monoclonal-antibody-for.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.41161613.effects-of-tetrahydrouridine-pre-dosing-on.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.41246456.frontier1-multiple-ascending-dose-extension-a.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.41257207.comparative-ex-vivo-analysis-of-mim8-in-thrombin.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.41296499.effect-of-semaglutide-on-insulin-sensitivity-and.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.41322967.haemophilia-b-an-illustrative-review-of-current.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.NN19b36bb998e.repurposing-glucagon-like-peptide-1-receptor.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.41380027.impact-of-oral-semaglutide-on-kidney-outcomes-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.41522368.baseline-characteristics-from-evoke-and-evoke.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.41527221.change-in-body-mass-index-and-disease-burden.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.41627802.oral-semaglutide-and-heart-failure-outcomes-in.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.NN19c566c0db3.factor-viii-in-vitro-bioequivalence-of-denecimig.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.41290376.effects-of-semaglutide-in-obesity-related-heart.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.41369941.rationale-design-and-baseline-clinical.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.41328546.cagrisema-reduces-blood-pressure-in-adults-with.htmlhttps://sciencehub.novonordisk.com/scientific-publications/articles/original-article.NN19d05b36ecc.efficacy-and-safety-of-oral-semaglutide-14-mg.html